Objective: This study investigated the role of the fat content of milk on symptoms of lactose intolerance. Design: Subjects recorded intolerance symptoms using a visual analogue scale (VAS) following ingestion of three test milks of varying fat content for a two-day period. Subjects/Setting: The subjects were thirty adult volunteers, patients of two Estonian out-patient clinics with diagnosed lactose intolerance. The study milks were drunk at home or at work. All thirty subjects completed the study protocol. Intervention: Each subject drank, in random order, fat-free milk (4.9% lactose), high-fat milk (8% fat, 4.9% lactose), and a lactose-free and fat-free control milk. They drank 200 ml of the milk twice a day for two days, one milk type per session, with ®ve days between sessions. The subjects noted their gastrointestinal symptoms during the test periods and during a 5 d milk-free period at the beginning of the study. The occurrence and severity of symptoms were compared. A global measure of the severity of symptoms was de®ned by computing the sum of the symptom scores. Results: The sum of symptoms was higher during all milk periods than during the milk-free period (P`0.01). There were no statistically signi®cant differences in the occurrence or severity of symptoms during the fat-free milk period compared with the high-fat milk period. Conclusions: Even a marked difference in the fat content of milk did not affect the symptoms of lactose intolerance. Consequently, there seems to be no case for recommending full-fat milk products in the treatment of lactose intolerance. Sponsorship: The study was supported by the Foundation of the Finnish Association of Agronomists: Valio Ltd, Finland, provided the test milks.
Introduction
It has been suggested that full-fat milk causes fewer symptoms in lactose maldigesters than lactose-free milk (Saavedra & Perman, 1989; Tamm, 1994) which seems to be contrary to general dietary recommendations that advocate low-fat milk products. The effect of the skimming of milk on the digestion of lactose is not known. Fat slows down the rate of gastric emptying (Houghton et al, 1990) , increases the jejunal transit time (Spiller et al, 1984) , and improves the absorption of carbohydrates (Holgate & Read, 1985) . Lactose digestion may be affected by simultaneous ingestion of fat, but the results of previous studies are contradictory. In infants and small children, low-fat milk may cause diarrhea and other symptoms of lactose intolerance which are alleviated by additional fat in the diet (Woolridge & Fisher, 1988) . Leichter (1973) and Solomons et al (1979) showed that, in adults, full-fat milk decreased lactose maldigestion and intolerance compared with fatfree milk or aqueous lactose solution, but other researchers (Cavalli-Sforza & Strata, 1986; Jones et al, 1976) have not been able to con®rm this result. Dehkordi et al (1995) demonstrated a slight decrease in the maldigestion of lactose in full-fat milk compared to fat-free milk, whereas there was no improvement in symptoms. Martini et al (1987) did not observe any signi®cant difference in the severity of symptoms or the degree of lactose maldigestion in lactose maldigesters who had consumed ice cream and ice milk with 10% and 3% fat respectively. However, the composition of ice cream and ice milk differs from that of milk, and the results may not be applicable to milk. In the previous studies the difference in the fat content has not been large (milk with 4% fat compared to fat-free milk or water). The aim of the present study was to investigate the effect of a considerable difference in the fat content of milk on the symptoms of lactose intolerance.
Materials and methods

Subjects
The study group consisted of 30 Estonian adult maldigesters (27 women, 3 men) from two out-patient clinics. Their mean age was 46 y, range 18±74 y. All had a history of milk intolerance. The subjects were healthy, without gastrointestinal diseases, were not receiving medication, and had not received antibiotic treatment for at least two months prior to the study. The irritable bowel syndrome had been excluded using the Rome criteria (Thompson et al, 1989) .
Diagnosis of lactose intolerance
All the subjects had undergone a screening test for lactose maldigestion. This had been determined by measuring the urinary galactose concentration after ingestion of 50 g of lactose with 150 mg of ethanol/kg body weight (Arola et al, 1987) , with a symptom follow-up during the test day. The possibility of secondary carbohydrate malabsorption had been excluded by a glucose-galactose test.
Test milks
Three types of milk were given to each subject, to be drunk at home or at work: (a) fat-free milk (0.1% fat, 4.9% lactose), (b) high-fat milk (8.0% fat, 4.9% lactose), (c) lactose-free milk (0.1% fat, 0% lactose). All milks were made from regular cow milk. The high-fat milk was prepared by mixing milk and cream and adding lactose, and the lactose-free milk was produced by the chromatographic method (Harju, 1987) . In order to assure that the milk was lactose-free, 0.05% of microbial lactase (EC 3.2.1.23), (Maxilact L-2000, Gist Brocades, France) was added. This milk was sweetened by fructose (1.5 g/0.1 l) to resemble the other milks. The milks were preserved by ultra-high temperature treatment 135 C/4 s and packed in white plastic packs. The fat content was analyzed by the Ro Èse-Gottlieb method (FIL-IDF standards 1 C: 1987 and 16 C:1987) , and the lactose content by a commercial Boehringer-Mannheim method (Cat. 986119).
Study design
Each milk was consumed in free-living conditions, in random order, over two consecutive days, twice a day, 0.2 l 1/2 h before breakfast and 0.2 l 1/2 h before lunch, with three hours between the ingestion of the milks. Thus, the total consumption of each milk was four doses. The tests were performed on the same days of the week (Tuesday and Wednesday) with ®ve days between each milk. A cross-over study design was used. The subjects were told only that the milks contained different amounts of lactose and fat. Completely blinded study setting was not possible, because full-fat milk can readily be discerned from fat-free milk. They were advised to keep the packs refrigerated, to consume them cold, and to shake them before use. On the test days, the subjects noted their gastrointestinal symptoms, namely¯atulence, nausea, abdominal pain and bloating, in a questionnaire using a 100 mm long horizontal visual analogue scale (VAS), where 0 indicates no symptoms and 100 very severe symptoms (Miller & Ferris, 1993) . The subjects marked each symptom on the visual analogue scale when the symptom started, and in cases where more severe symptoms occurred at a later period in the day, these were marked as well. If no symptoms were present, at the end of the day the subject marked the`nosymptoms' end of the VAS line. In addition, the starting time of the symptoms and the consistency and number of stools on the test day were inquired about. In the statistical analyses, only the symptoms that occurred within nine hours of ingestion of the second test milk were taken into account.
The subjects were asked to follow a lactose-free diet during the study and were given a list of products that contain lactose. Before the test period, there was a control period when they recorded normal gastrointestinal symptoms for at least ®ve days on the advised lactose-free diet. Only two days (Tuesday and Wednesday) were included in the statistical analyses. They were questioned during the study about the use of dairy products. The procedures followed were approved by the ethical committee of the Foundation for Nutrition Research.
Statistics
All analyses were carried out using the STATISTICA/w statistical package (Release 4.5; StatSoft Inc., Tulsa, OK). A global measure of the severity of symptoms was de®ned by forming the sum of VAS values for abdominal bloating, abdominal pain,¯atulence and nausea (scale 0±400). The inter-quartile range (IQR) was used to demonstrate the variance within the study group. The IQR includes 50% of all observations. The McNemar test was used to compare the occurrence of symptoms, and the Wilcoxon signed rank sum test was used to compare the severity of symptoms during the test periods (Armitage & Berry, 1994) . Statistical signi®cance was de®ned as P`0.05. In the tables the statistical signi®cances are indicated by * for P`0.05, ** for P`0.01, and *** for P`0.001.
Results
The differences in the prevalence or severity of symptoms were not statistically signi®cant between the fat-free and the high-fat milk periods (Tables 1±3). According to the sum of the symptoms, the subjects experienced more severe symptoms during all milk periods than during the milk-free period (P 0.02, Table 2 ).
Flatulence was more severe during all milk periods compared to the milk-free period, but the difference reached statistical signi®cance only for the two lactosecontaining milks (P`0.05, Table 2 ). During the lactosefree milk period, nausea was more severe (P 0.04) than during the milk-free period. The number of stools was higher during all three test milk periods than during the milk-free period (P`0.05), but there was no difference in the hardness of the stools (Table 3) .
Discussion
The results of the present study support most of the earlier reports in which no difference was noted in the tolerance of lactose in fatty milk compared with fat-free milk (CavalliSforza & Strata, 1986; Dehkordi et al 1995; Jones et al 1976) . The results of Leichter (1973) were contradictory to our ®ndings, but in his study, statistical comparisons of the symptoms were not presented, and there was no mention of randomization of the test periods. We have shown in our recent experiments (Briet et al, 1996) that the same product consumed twice, in a blind setting, caused more symptoms the ®rst time than the second occasion, and also that the orocaecal transit time was shorter on the ®rst time. The order of the test periods may in¯uence gastrointestinal symptoms, and therefore only the results of randomized studies are reliable.
Lactose has been shown, in breath hydrogen tests, to be better digested in milk than in aqueous lactose solution *P`0.05, **P`0.01 compared with the milk-free period. There were no signi®cant differences between the test milk periods. (Solomons et al, 1979; Solomons et al, 1980) . It has been proposed that the improved digestion may be due to the many components of milk and augmented energy content that delay gastric emptying and intestinal motility, which increase the time of hydrolysis of lactose in the intestine. However, Welsh & Hall (1977) did not ®nd any difference in lactose maldigesters in the gastric emptying of lactose in water and 2% fat milk of similar osmolarity and volume. This may have been due to the low fat content of the milk or to the small number of subjects used in the study. Since the addition of fat to a meal is known to delay gastric emptying (Spiller et al, 1984) , it is possible that there is at least a slight difference in the digestion of lactose between high-fat milk and fat-free milk. This difference would not, however, be clinically important, for an alleviation of symptoms has not been well documented despite several studies in that ®eld. In our study even small differences in the symptoms should have been seen, for the VAS is a valid method for measuring small changes in a phenomenon (Miller & Ferris, 1993) . Cognizance of lactose digestion after ingestion of the milks would have been useful, but we decided to study free-living subjects, because laboratory conditions might have affected the neurologically controlled gastrointestinal functions, as well as the symptom perception, and because our intention was to study symptoms, which are of more relevance to the individual than lactose digestion. The lactose-free milk induced symptoms in some of the study group. One explanation for this might be the fructose added to the milk in order to equalize its sweetness and osmolarity with the other milks. Unfortunately, the role of fructose in inducing symptoms in this study cannot be de®nitively determined, and there is a slight possibility that it caused symptoms in the most sensitive subjects. Its in¯uence should not, however, be very important. Gerrits & Tsalikian (1993) mentioned that most investigators who have worked extensively with fructose supplemented diets believe that moderate amounts of fructose do not cause intolerance symptoms, although excess amounts are reported to produce gastrointestinal disturbances. The amount used in our study was fairly small (3 g twice a day).
One explanation why lactose-free milk induced as many symptoms as the lactose containing milks may be that lactose intolerant persons are sensitive to several liquids and substances independent of lactose, as seen also in earlier studies (Johnson et al, 1993; Suarez et al, 1995; Vesa et al, 1996) , or the symptoms may be due to a placebo effect of milk. In general, however, the symptoms during all test periods were mild. The subjects reported more nausea during all test periods than during the milk-free period, which may demonstrate an overall adverse response towards milk. All subjects had been aware of their milk intolerance prior to the study, and this might have caused a psychological/nervous symptom response, although they were told at the beginning of the study that all the milks were not regular milk and might not induce symptoms the same manner as regular milk does.
It has been proposed that milk fat induces symptoms in some individuals (Costet et al, 1983) . This was not the case in our study, for both high-fat milk and fat-free milk were equally well tolerated. It was interesting to note that ingestion of milk without regard to its lactose content increased the number of stools per day compared with the milk-free period. This could be due either to a laxative effect of milk or possibly to an increased ingestion of¯uid from the test milks. The amount of¯uid ingested during the study was not determined. The conclusion is that the occurrence or severity of symptoms was not affected by the fat content of the milk. The general recommendation to choose low-fat and fat-free milk products for preference seems to be applicable to lactose maldigesters also. a The values are the mean and (the inter quartile range), n 30. b 0 (no symptoms)±100 (very severe symptoms). c Flatulence abdominal bloating abdominal pain nausea (scale 0-400). *P`0.05, **P`0.01 compared with the milk-free period. There were no signi®cant differences between the testmilk periods. Values are the mean and (the inter-quartile range), n 30. b 0 (very loose)±100 (very hard). *P`0.05 compared with the milk-free period. There were no signi®cant differences between the test-milk periods.
